Related Experiment Video
Updated: Apr 4, 2026

04:40
Tactile Semiautomatic Passive-Finger Angle Stimulator TSPAS
Published on: July 30, 2020
3.4K
Abnormal tactile pressure perception in Parkinson's disease.
Tigran Kesayan1, Damon G Lamb, Adam D Falchook
1a Department of Neurology , University of Florida , Gainesville , FL , USA.
Journal of Clinical and Experimental Neuropsychology
|August 28, 2015
Summary
People with Parkinson's disease (PD) show impaired tactile sensory perception, overestimating weaker stimuli and underestimating stronger ones. This suggests a cognitive disengagement deficit, potentially linked to frontal-executive dysfunction in PD.
Area of Science:
- Neuroscience
- Sensory Perception
- Cognitive Psychology
Background:
- Parkinson's disease (PD) is associated with behavioral disorders like hypometria, possibly due to impaired cognitive disengagement.
- Difficulty disengaging attention can alter sensory perception, leading to a contracted range of estimated stimulus magnitudes.
Purpose of the Study:
- To investigate the disengagement hypothesis in Parkinson's disease.
- To determine if individuals with PD exhibit abnormal tactile sensory perception.
Main Methods:
- 12 participants with PD and 12 healthy controls were tested.
- Tactile stimuli of varying magnitudes were applied to the palm using Semmes-Weinstein monofilaments.
- Participants estimated the magnitude of test stimuli relative to a standard stimulus.
Main Results:
- Participants with PD overestimated the magnitude of tactile stimuli weaker than the standard.
- Individuals with PD underestimated the magnitude of tactile stimuli stronger than the standard.
- A significant difference in relative magnitude estimation was observed between the PD and control groups.
Conclusions:
- Individuals with Parkinson's disease demonstrate reduced ability in estimating relative tactile stimulus magnitudes.
- The observed perceptual impairment in PD may stem from a disorder of cognitive disengagement.
- Disorders of disengagement are frequently associated with frontal-executive dysfunction.
Related Concept Videos
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Parkinson's Disease: Overview
2.4K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.4K
Neural Regulation
44.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.9K
Somatosensation
45.7K
The somatosensory system relays sensory information from the skin, mucous membranes, limbs, and joints. Somatosensation is more familiarly known as the sense of touch. A typical somatosensory pathway includes three types of long neurons: primary, secondary, and tertiary. Primary neurons have cell bodies located near the spinal cord in groups of neurons called dorsal root ganglia. The sensory neurons of ganglia innervate designated areas of skin called dermatomes.
45.7K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
681
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
681

